Herceptin

Latest stories

2h
San Antonio Express-News
Why Halozyme Therapeutics Inc Plunged 51% in JanuaryWhat: Investors in human-enzyme specialist Halozyme Therapeutics had a month to
Why Halozyme Therapeutics Inc Plunged 51% in January
San Antonio Express-News / Posted 2 hours ago
What: Investors in human-enzyme specialist Halozyme Therapeutics had a month to forget, as its shares lost 51% of their value in January, according to data from S&P Capital IQ. So what: With a drop like that, you'd expect that the company had a... Read more
1d
San Antonio Express-News
ImmunoGen, Inc.'s Earnings Play the Amortization BluesImmunoGen released earnings for its second fiscal quarter on Friday, but with t
ImmunoGen, Inc.'s Earnings Play the Amortization Blues
San Antonio Express-News / Posted yesterday
ImmunoGen released earnings for its second fiscal quarter on Friday, but with the lack of any meaningful revenue, it was the update on its pipeline investors should be most interested in. Don't freak out about ImmunoGen going from a profit to a... Read more
2d
Daily Record
Fearless Scots cancer survivor celebrates all-clear with 15,000ft skydiveThe skydive over stunning Lake Taupo was captured on a video which Claire-Ann t
Fearless Scots cancer survivor celebrates all-clear with 15,000ft skydive
Daily Record / Posted 2 days ago
The skydive over stunning Lake Taupo was captured on a video which Claire-Ann treasures. She signed up for the jump as part of an action-packed, seven-week trip in October to destinations including Bangkok, Vietnam, Australia, New Zealand and... Read more
6 related stories
2d
EveningTimes Online
Cancer death rates falling, new figures to mark World Cancer Day revealCANCER death rates in Scotland have fallen by 9 per cent in the last 10 years,
Cancer death rates falling, new figures to mark World Cancer Day reveal
EveningTimes Online / Posted 2 days ago
CANCER death rates in Scotland have fallen by 9 per cent in the last 10 years, according to new figures released today on World Cancer Day by Cancer Research UK. As told earlier this week in the Evening Times, Cancer Research UK is encouraging Scots... Read more
6 related stories
5d
The Columbian
Drug may help breast cancer patients avoid heart damageORLANDO, Fla. — Many cancer treatments have a dark side — they can damage the h
Drug may help breast cancer patients avoid heart damage
The Columbian / Posted 5 days ago
ORLANDO, Fla. — Many cancer treatments have a dark side — they can damage the heart. New research suggests this risk might be lowered in women with breast tumors if they take a heart drug as a preventive measure during their cancer care. If... Read more
6d
San Antonio Express-News
3 High-Risk Dividend Stocks I'd AvoidMost investors love dividend stocks, and for good reasons. Statistical studies
3 High-Risk Dividend Stocks I'd Avoid
San Antonio Express-News / Posted 6 days ago
Most investors love dividend stocks, and for good reasons. Statistical studies have proven time and again that investing in companies with strong dividends can be a powerful strategy to achieve superior returns from your portfolio over the long... Read more
10d
News-Medical-Net
Nutrition and breast cancer; starving triple negative breast cancer cells to death: an interview with Associate Professor Jeff HolstCan you give me a brief overview of the role that nutrition plays in breast can
Nutrition and breast cancer; starving triple negative breast cancer cells to death: an interview with Associate Professor Jeff Holst
News-Medical-Net / Posted 10 days ago
Can you give me a brief overview of the role that nutrition plays in breast cancer? While there are a range of reports that different foods and food groups can increase or decrease your risk of cancer, these associations are very difficult to... Read more
12d
Belfast Telegraph
Animal testing is crucial for science The use of animals in research is an invaluable tool for scientists, leading
Animal testing is crucial for science
Belfast Telegraph / Posted 12 days ago
The use of animals in research is an invaluable tool for scientists, leading to treatments which include insulin for diabetics, penicillin, modern cancer treatments like Herceptin and every human and animal... Read more
16d
Business Wire
BIOCAD annonce l'approbation du premier médicament biosimilaire du Trastuzumab par le Ministère de la Santé de la Fédération de RussieSAINT PETERSBOURG, Russie--(BUSINESS WIRE)--Le médicament biosimilaire du Trast
BIOCAD annonce l'approbation du premier médicament biosimilaire du Trastuzumab par le Ministère de la Santé de la Fédération de Russie
Business Wire / Posted 16 days ago
SAINT PETERSBOURG, Russie--(BUSINESS WIRE)--Le médicament biosimilaire du Trastuzumab, qui sera commercialisé sous le nom de HERtiCAD™, est le premier médicament biosimilaire du même nom à obtenir l'autorisation de mise sur le marché de l'organisme... Read more
416 related stories
16d
Business Wire
BIOCAD gibt das erste vom Gesundheitsministerium der Russischen Föderation zugelassene Trastuzumab Biosimilar bekanntSANKT PETERSBURG, Russland--(BUSINESS WIRE)--Das unter dem Handelsnamen HERtiCA
BIOCAD gibt das erste vom Gesundheitsministerium der Russischen Föderation zugelassene Trastuzumab Biosimilar bekannt
Business Wire / Posted 16 days ago
SANKT PETERSBURG, Russland--(BUSINESS WIRE)--Das unter dem Handelsnamen HERtiCAD™ vermarktete Trastuzumab Biosimilar ist das erste Trastuzumab Biosimilar, das die Zulassung der russischen Aufsichtsbehörde erhält. Die Marktzulassung des Trastuzumab... Read more
2823 related stories
16d
Ventura County Star
Westlake Village scientist indicted in secrets case involving ChinaA Westlake Village resident is among two Glaxo Smith Kline scientists charged a
Westlake Village scientist indicted in secrets case involving China
Ventura County Star / Posted 16 days ago
A Westlake Village resident is among two Glaxo Smith Kline scientists charged along with three others with conspiracy to steal promising cancer research secrets from the pharmaceutical giant and market them to companies in China backed by the Chinese... Read more
2 related stories
16d
WA Today
Five scientists indicted in secrets case involving ChinaA drug laboratory. Photo: Bloomberg Philadelphia: Two Glaxo Smith Kline scien
Five scientists indicted in secrets case involving China
WA Today / Posted 16 days ago
A drug laboratory. Photo: Bloomberg Philadelphia: Two Glaxo Smith Kline scientists and three others were charged by a federal grand jury in Philadelphia on Wednesday with conspiracy to steal promising cancer research secrets from the pharmaceutical... Read more
2 related stories
19d
Oxford Mail
A sweeter treatment for breast cancer: scientists use sugar to deliver drugsOxford scientists have found a new and better way to kill breast cancer by stic
A sweeter treatment for breast cancer: scientists use sugar to deliver drugs
Oxford Mail / Posted 19 days ago
Oxford scientists have found a new and better way to kill breast cancer by sticking drugs to antibodies with sugar. The team, funded by Abingdon charity Against Breast Cancer, discovered they could even control the amount of drug that stuck on and... Read more
19d
Business Wire
Samsung Bioepis Ingresa al Mercado Biofarmacéutico Europeo con Benepali®, la Primera Fusión de Proteínas Biosimilares Aprobada por la Comisión EuropeaINCHEON, Corea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. anunció hoy la aprob
Samsung Bioepis Ingresa al Mercado Biofarmacéutico Europeo con Benepali®, la Primera Fusión de Proteínas Biosimilares Aprobada por la Comisión Europea
Business Wire / Posted 19 days ago
INCHEON, Corea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. anunció hoy la aprobación de la Comisión Europea (CE) de Benepali®, un biosimilar referido a Enbrel® (etanercept), también conocido como SB4, para el tratamiento de la artritis reumatoidea,... Read more
3536 related stories
19d
Business Wire
Samsung Bioepis entra no mercado biofarmacêutico europeu com o Benepali®, a primeira proteína biossimilar de fusão aprovada pela Comissão EuropeiaINCHEON, Coreia--(BUSINESS WIRE)--A Samsung Bioepis Co., Ltd. anunciou hoje a a
Samsung Bioepis entra no mercado biofarmacêutico europeu com o Benepali®, a primeira proteína biossimilar de fusão aprovada pela Comissão Europeia
Business Wire / Posted 19 days ago
INCHEON, Coreia--(BUSINESS WIRE)--A Samsung Bioepis Co., Ltd. anunciou hoje a aprovação da Comissão Europeia (CE) para o Benepali® – um biossimilar que faz referência ao Enbrel® (etanercept), também conhecido como SB4 – para o tratamento de artrite... Read more
418 related stories
19d
National Post
Story | Business Wire News Releases | News | Financial PostEn seulement quatre ans, Samsung Bioepis a développé, testé et obtenu l'approba
Story | Business Wire News Releases | News | Financial Post
National Post / Posted 19 days ago
En seulement quatre ans, Samsung Bioepis a développé, testé et obtenu l'approbation règlementaire du Benepali®, premier biosimilaire de l'étanercept dans l'Union européenne L'approbation de la Commission européenne s'applique aux 28 États membres de... Read more
416 related stories
19d
Business Wire
Samsung Bioepis tritt mit Benepali® – dem ersten von der EU-Kommission zugelassenen Fusionsprotein-Biosimuar – in den europäischen Biopharma-Markt einINCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. hat heute berichtet,
Samsung Bioepis tritt mit Benepali® – dem ersten von der EU-Kommission zugelassenen Fusionsprotein-Biosimuar – in den europäischen Biopharma-Markt ein
Business Wire / Posted 19 days ago
INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. hat heute berichtet, dass die Europäische Kommission Benepali® – ein Biosimilar zu Enbrel® (Etanercept), auch unter der Bezeichnung SB4 bekannt – zur Behandlung von rheumatoider Arthritis,... Read more
2823 related stories
19d
Business Wire
Samsung Bioepis pénètre le marché européen des produits biopharmaceutique avec Benepali®, le premier biosimilaire des protéines de fusion approuvé par la Commission européenneINCHEON, Corée--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. a annoncé aujourd'hu
Samsung Bioepis pénètre le marché européen des produits biopharmaceutique avec Benepali®, le premier biosimilaire des protéines de fusion approuvé par la Commission européenne
Business Wire / Posted 19 days ago
INCHEON, Corée--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. a annoncé aujourd'hui l'approbation du Benepali® – un biosimilaire référençant Enbrel® (étanercept), également appelé SB4 – de la part de la Commission européenne (CE) pour le traitement de... Read more
416 related stories
19d
Business Wire
Samsung Bioepis accede al mercato biofarmaceutico europeo con Benepali®, il primo biosimilare di proteina di fusione approvato dalla Commissione EuropeaINCHEON, Corea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. ha annunciato oggi l
Samsung Bioepis accede al mercato biofarmaceutico europeo con Benepali®, il primo biosimilare di proteina di fusione approvato dalla Commissione Europea
Business Wire / Posted 19 days ago
INCHEON, Corea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. ha annunciato oggi l'approvazione da parte della Commissione Europea (CE) di Benepali® - un biosimilare di Enbrel® (etanercept), noto anche come SB4, per il trattamento dell'artrite... Read more
53 related stories
20d
Channel NewsAsia
Samsung Bioepis' Enbrel drug copy gets EU approvalSEOUL: Samsung Bioepis Co Ltd said on Sunday it had received European Commissio
Samsung Bioepis' Enbrel drug copy gets EU approval
Channel NewsAsia / Posted 20 days ago
SEOUL: Samsung Bioepis Co Ltd said on Sunday it had received European Commission approval for its copy of the blockbuster biotech arthritis drug Enbrel. The drug, known scientifically as etanercept, will be sold in Europe by U.S. biotechnology group... Read more
20d
Business Wire
Samsung Bioepis Enters the European Biopharmaceutical Market with Benepali®, the First Fusion Protein Biosimilar Approved by the European CommissionINCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced the
Samsung Bioepis Enters the European Biopharmaceutical Market with Benepali®, the First Fusion Protein Biosimilar Approved by the European Commission
Business Wire / Posted 20 days ago
INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a biosimilar referencing Enbrel® (etanercept), also known as SB4 – for the treatment of rheumatoid arthritis, psoriatic... Read more
21d
People Magazine
Amber Marchese's Blog: How a Christmas Miracle' Helped Make Me Ready to Take on 2016 Then, the day before my seventh treatment of Herceptin and Perjeta, I am told
Amber Marchese's Blog: How a Christmas Miracle' Helped Make Me Ready to Take on 2016
People Magazine / Posted 21 days ago
Then, the day before my seventh treatment of Herceptin and Perjeta, I am told that my medical insurance company, AmeriHealth, made the decision for me that I am no... Read more
22d
FOX News
A cause for celebration: FDA fast-tracks breast cancer drugWhat’s more exciting than World Cancer Day, on Feb. 4, a day that shines a ligh
A cause for celebration: FDA fast-tracks breast cancer drug
FOX News / Posted 22 days ago
What’s more exciting than World Cancer Day, on Feb. 4, a day that shines a light on this dreadful, life-killing disease? The answer is the Food and Drug Administration’s (FDA) approval on Tuesday of a ground-breaking drug for those who suffer with... Read more

People in this news